NASDAQ$IDXX
IDEXX Laboratories Inc · Q3 2023 earnings
Q3 2023 earnings · · Investor relations
Briefing
IDEXX achieved revenue growth and EPS growth, driven by CAG Diagnostics recurring revenue growth and operating margin expansion.
IDEXX Laboratories reported a 9% increase in revenue and an 18% increase in EPS for the third quarter of 2023. The growth was driven by strong performance in the Companion Animal Group (CAG) and Water segments. The company has updated its full-year revenue and EPS outlook.
- IDEXX achieved third quarter revenue growth of 9% reported and 8% organic, driven by CAG Diagnostics recurring revenue growth of 10% reported and 9% organic.
- Revenue growth reflects benefits from IDEXX execution drivers including double-digit year-over-year installed base growth across global premium instrument platforms.
- The company delivered EPS of $2.53, representing 18% growth as reported and 16% on a comparable basis, supported by operating margin expansion of 100 basis points as reported and 140 basis points on a comparable basis.
- IDEXX adjusted 2023 revenue guidance to $3,635 million - $3,650 million and updated 2023 EPS outlook to $9.74 - $9.90.
Headline financials
Revenue & EPS history
IDEXX · Revenue · Quarterly
$916M
Revenue by segment
IDEXX · $829M total across 9 segments · Q4 2022
- Reference labs$283M+4.2%34.2%
- VetLab consumables$261M+3.8%31.5%
- Rapid assay products$71.1M+7.1%8.6%
- Vet software & imaging$66.9M+15.3%8.1%
- Water$39.3M+5.9%4.7%
- Dx capital instruments$38.9M-10.5%4.7%
- LPD$33.4M-1.7%4.0%
- Dx services & accessories$27.1M-2.1%3.3%
- Other$7.33M-32.7%0.9%
Forward guidance
IDEXX is updating its full year revenue growth outlook range to 7.9% - 8.4% as reported and 8.3% - 8.8% organically. The Company updated its EPS outlook range to $9.74 - $9.90.
Tailwinds
- Revenue $3,635 - $3,650 million
- Reported growth 7.9% - 8.4%
- Organic growth 8.3% - 8.8%
- CAG Diagnostics Recurring Revenue Growth Reported growth 9.4% - 9.9%
- CAG Diagnostics Recurring Revenue Growth Organic growth 9.8% - 10.3%
Headwinds
- Operating Margin 29.6% - 29.8%
- Operating margin expansion 290 bps - 310 bps
- Negative impact of foreign exchange ~ 70 bps
- Comparable margin expansion 360 bps - 380 bps
- Positive impact of discrete in-license of technology and customer contract resolution ~ 280 bps
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2023
+0.7%
Avg return
Earnings day
+1.4%
Avg return
5 days after
+2.8%
Avg return
30 days after
43%
30 / 69 earnings
Positive
+27.5%
Q2 2025
Best reaction
-18.9%
Q1 2015
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +3.4% | -0.6% | -0.1% | |
| Q4 2025 | -4.8% | -3.9% | -3.2% | |
| Q3 2025 | +14.9% | +12.5% | +15.3% | |
| Q2 2025 | +27.5% | +22.9% | +18.4% | |
| Q1 2025 | +9.0% | +9.5% | +18.7% | |
| Q4 2024 | +11.1% | +8.9% | +3.6% | |
| Q3 2024 | -7.5% | -7.8% | -6.5% | |
| Q2 2024 | +2.6% | +6.1% | +3.1% | |
| Q1 2024 | -3.4% | -3.2% | +0.9% | |
| Q4 2023 | +7.6% | +8.5% | +5.8% | |
| Q3 2023 | +5.0% | +5.9% | +20.8% | |
| Q2 2023 | -6.4% | -9.1% | -7.8% | |
| Q1 2023 | -2.2% | -0.2% | -4.0% | |
| Q4 2022 | +5.2% | +0.7% | -0.0% | |
| Q3 2022 | +3.6% | +3.4% | +22.1% | |
| Q2 2022 | +2.2% | +2.4% | -12.1% | |
| Q1 2022 | -11.7% | -20.9% | -14.5% | |
| Q4 2021 | +5.0% | +0.8% | +4.3% | |
| Q3 2021 | -6.1% | -4.4% | -10.1% | |
| Q2 2021 | -3.6% | -0.8% | -5.1% | |
| Q1 2021 | -3.6% | -1.0% | +0.1% | |
| Q4 2020 | -1.4% | +2.1% | -1.3% | |
| Q3 2020 | +0.5% | +5.0% | +7.4% | |
| Q2 2020 | +4.8% | +5.8% | +2.6% | |
| Q1 2020 | -0.7% | +3.4% | +13.3% | |
| Q4 2019 | -2.8% | -3.3% | -10.3% | |
| Q3 2019 | +1.1% | -3.5% | -8.1% | |
| Q2 2019 | -4.7% | -4.1% | +2.7% | |
| Q1 2019 | +4.5% | +8.6% | +7.7% | |
| Q4 2018 | -4.5% | -1.9% | +1.5% | |
| Q3 2018 | -3.4% | -4.6% | -3.9% | |
| Q2 2018 | -1.7% | -0.8% | +3.7% | |
| Q1 2018 | +6.0% | +5.5% | +10.0% | |
| Q4 2017 | -0.4% | -3.7% | -0.7% | |
| Q3 2017 | -3.1% | -5.4% | -4.9% | |
| Q2 2017 | -9.2% | -8.3% | -6.6% | |
| Q1 2017 | +0.6% | -1.5% | +2.9% | |
| Q4 2016 | +15.7% | +16.6% | +19.8% | |
| Q3 2016 | -1.6% | -0.9% | +6.6% | |
| Q2 2016 | +15.5% | +16.6% | +21.0% | |
| Q1 2016 | +5.6% | — | — | |
| Q4 2015 | +10.4% | — | — | |
| Q3 2015 | -8.8% | — | — | |
| Q2 2015 | +9.4% | — | — | |
| Q1 2015 | -18.9% | — | — | |
| Q4 2014 | -3.1% | — | — | |
| Q3 2014 | +9.8% | — | — | |
| Q2 2014 | -2.7% | — | — | |
| Q1 2014 | +2.9% | — | — | |
| Q4 2013 | +6.5% | — | — | |
| Q3 2013 | -1.0% | — | — | |
| Q2 2013 | -0.6% | — | — | |
| Q1 2013 | -6.4% | — | — | |
| Q4 2012 | -3.5% | — | — | |
| Q3 2012 | -1.1% | — | — | |
| Q2 2012 | -5.3% | — | — | |
| Q1 2012 | -3.4% | — | — | |
| Q4 2011 | -0.5% | — | — | |
| Q3 2011 | +3.2% | — | — | |
| Q2 2011 | +6.3% | — | — | |
| Q1 2010 | +0.0% | — | — | |
| Q1 2011 | +3.0% | — | — | |
| Q4 2008 | -3.9% | — | — | |
| Q4 2010 | -3.9% | — | — | |
| Q3 2009 | -1.4% | — | — | |
| Q3 2010 | -1.4% | — | — | |
| Q4 2009 | -2.7% | — | — | |
| Q2 2009 | -2.7% | — | — | |
| Q2 2010 | -2.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro